Recently, others and we reported that CD147 is overexpressed in highly aggressive pancreatic cancer and acts as a novel upstream activator in STAT3-mediated pancreatic tumor development [24, 25]. The gene discussed is BSG; the disease is familial pancreatic carcinoma.